Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancer

Nicholas Scott-Wittenborn, Gypsyamber D'Souza, Nafi Aygun, Sakshi R. Tewari, Javad Azadi, Peter Vosler, Zhen Gooi, Vikas Mehta, Wojciech Mydlarz, Melonie Nance, Stefan Mlot, Mihir R. Patel, Marietta Tan, Brett A. Miles, Tanya Troy, Carole Fakhry

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Human papillomavirus-associated oropharynx squamous cell carcinoma (HPV-OPSCC) has no known pre-malignant lesion. While vaccination offers future primary prevention, there is current interest in secondary prevention. The feasibility of clinical evaluation of individuals at increased risk for HPV-OPSCC is unclear. Methods: Individuals with risk factors for HPV-OPSCC were enrolled in a prospective study (MOUTH). Participants positive for biomarkers associated with HPV-OPSCC were eligible for a clinical evaluation which comprised a head and neck examination and imaging with ultrasound and/or magnetic resonance imaging (MRI). This study was designed to evaluate feasibility of clinical evaluation in a screening study. Results: Three hundred and eighty-four participants were eligible for clinical evaluation. Of the 384, 204 (53%) completed a head and neck examination or imaging. Of these, 66 (32%) completed MRI (n = 51) and/or ultrasound (n = 64) studies. Conclusions: Clinical evaluations, including head and neck examination and imaging, are feasible in the context of a screening study for HPV-OPSCC.

Original languageEnglish (US)
Pages (from-to)95-102
Number of pages8
JournalHead and Neck
Volume45
Issue number1
DOIs
StatePublished - Jan 2023

Keywords

  • HPV
  • MRI
  • head and neck cancer
  • oropharyngeal cancer
  • ultrasound

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint

Dive into the research topics of 'Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancer'. Together they form a unique fingerprint.

Cite this